https://www.selleckchem.com/pr....oducts/DMXAA(ASA404)
in Australian adults. BACKGROUND Vaccination is the most effective approach to prevent infection with highly pathogenic avian influenza (HPAI). Adjuvants are often used to induce effective immune responses and overcome the immunological weakness of recombinant HPAI antigens. Given the logistical challenges of immunization to HPAI during pandemic situations, vaccines administered via the intramuscular (I.M.) route would be of value. METHODS A new formulation of nanoemulsion adjuvant (NE02) suitable for I.M. vaccination was develope
Like
Comment
Share
